[Management of metastatic castration-resistant prostate cancer following docetaxel].;Prise en charge des cancers de prostate résistants à la castration métastatiques après échec du docétaxel.

Bulletin du cancer

Volumn 99 Suppl 1, Issue , 2012, Pages

  Beuzeboc, Philippe ^a   Ropert, Stanislas ^b   Goldwasser, François ^b   Zerbib, Marc ^b  

^a INSTITUT CURIE   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

17 (3 PYRIDYL) 5,16 ANDROSTADIEN 3BETA ACETATE; 17-(3-PYRIDYL)-5,16-ANDROSTADIEN-3BETA-ACETATE; ANDROSTANE DERIVATIVE; ANGIOGENESIS INHIBITOR; ANTIANDROGEN; ANTINEOPLASTIC AGENT; CABAZITAXEL; DOCETAXEL; DRUG DERIVATIVE; ENZALUTAMIDE; PHENYLTHIOHYDANTOIN; RADIOISOTOPE; RADIUM; RADIUM CHLORIDE RA 223; TAXOID;

HUMAN; MALE; ORCHIECTOMY; PROGNOSIS; PROSTATE TUMOR; REVIEW; TREATMENT FAILURE; VASCULARIZATION;

ANDROGEN ANTAGONISTS; ANDROSTADIENES; ANGIOGENESIS INHIBITORS; ANTINEOPLASTIC AGENTS; HUMANS; MALE; ORCHIECTOMY; PHENYLTHIOHYDANTOIN; PROGNOSIS; PROSTATIC NEOPLASMS; RADIOISOTOPES; RADIUM; TAXOIDS; TREATMENT FAILURE;

EID: 84878943372     PISSN: None     EISSN: 17696917     Source Type: None    
DOI: None     Document Type: Review

References (0)